3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
3
Esophageal Neoplasms
2
Esophageal Squamous Cell Carcinoma
1
Adenocarcinoma of Lung
1
Interventions
Cisplatin
3
toripalimab
2
sintilimab
2
Radiation
2
camrelizumab
1
anlotinib
1
TP protocol
1
Radiotherapy
1
Platinum Compounds
1
Paclitaxel
1
Nivolumab
1
Neoadjuvant Therapy
1
Immune Checkpoint Inhibitors
1
Fluorouracil
1
Docetaxel
1
Chemoradiotherapy
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Esophageal Squamous Cell Carcinoma
×
Platinum Compounds
×
Clear all
NCT07629817
2026-06-05
HCHTOG2603
Henan Cancer Hospital
Phase 3
Not yet recruiting
1,044 enrolled